This inventor holds 54 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Cancer Therapeutics (CPC class C07D). Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Walter and Eliza Hall Institute of Medical Research. Active years: 2005-2024.
Inventors with similar research interests:
Location History:
- Gurnee, IL (US) (2005 - 2012)
- Northbrook, IL (US) (2008 - 2024)
Company Filing History:
29 out of 826 
25 out of 4,186 
8 out of 84 
Years Active: 2005-2024
Areas of Expertise:
Title: Steven Elmore: A Pioneer in Cancer Treatment Innovations
Introduction
Steven Elmore, a prolific inventor based in Northbrook, IL, is renowned for his significant contributions to the field of medicine, particularly in the treatment of cancer and autoimmune diseases. With an impressive portfolio of 54 patents, his work exemplifies the intersection of scientific innovation and practical application.
Latest Patents
Among Steven's latest patents is a groundbreaking invention titled "Apoptosis Inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases." This patent discloses compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, along with methods of treating diseases characterized by the expression of these proteins. Furthermore, another notable patent focuses on "Methods of Treatment Using Selective Bcl-2 Inhibitors." This invention proposes treatment methods for systemic lupus erythematosus and Sjögren's Syndrome utilizing compounds that specifically inhibit Bcl-2 proteins while exhibiting a lesser affinity for other BCL-2 family proteins.
Career Highlights
Throughout his career, Steven has held key positions at prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His extensive experience in these organizations has played a pivotal role in shaping his innovative approach to developing new therapeutic methods.
Collaborations
Steven has collaborated with esteemed colleagues, including Xilu Wang and Andrew J Souers, enhancing the breadth of his research and development endeavors. These collaborations have further propelled advancements in the treatment of complex diseases.
Conclusion
In conclusion, Steven Elmore stands out as a leading inventor whose work has greatly influenced the pharmaceutical landscape, particularly in cancer treatment and autoimmune disease therapies. His remarkable patents and career achievements underscore his commitment to improving patient outcomes through innovative scientific solutions.